Immunogenicity of Heterologous Versus Homologous Prime Boost Schedule With mRNA and Inactivated COVID-19 Vaccines
Clinical trial NCT05668065 · COMPLETED
Trial details
- NCT number
- NCT05668065
- Sponsor
- Institut Pasteur de Tunis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-22
- Primary completion
- 2022-01-31
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.